Breaking News

Almac Expands Analytical Services Capability

Investing nearly $500M in NMR equipment

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Almac Group has unveiled plans for a £375,000 (~$500mn) investment in additional NMR instrumentation at its global headquarters in Craigavon, UK. As part of Almac Sciences’ state-of-the-art cGMP facility, enhanced NMR services will be offered to help deliver comprehensive solutions supporting drug substance (API) and drug product development programs from early phase to commercialization. These services include advanced characterization and purity assessment abilities in line with regul...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters